238 related articles for article (PubMed ID: 7951317)
1. Cooperative tumorigenic effects of germline mutations in Rb and p53.
Williams BO; Remington L; Albert DM; Mukai S; Bronson RT; Jacks T
Nat Genet; 1994 Aug; 7(4):480-4. PubMed ID: 7951317
[TBL] [Abstract][Full Text] [Related]
2. Effects of an Rb mutation in the mouse.
Jacks T; Fazeli A; Schmitt EM; Bronson RT; Goodell MA; Weinberg RA
Nature; 1992 Sep; 359(6393):295-300. PubMed ID: 1406933
[TBL] [Abstract][Full Text] [Related]
3. Mice deficient in both p53 and Rb develop tumors primarily of endocrine origin.
Harvey M; Vogel H; Lee EY; Bradley A; Donehower LA
Cancer Res; 1995 Mar; 55(5):1146-51. PubMed ID: 7867001
[TBL] [Abstract][Full Text] [Related]
4. Protein expression of p53 and Rb suppressor genes during the first passages of human endometrial adenocarcinomas heterotransplanted into nude mice.
Horvath G; Leser G; Delle U
In Vivo; 1995; 9(1):41-8. PubMed ID: 7669947
[TBL] [Abstract][Full Text] [Related]
5. [Tumor suppressor genes: mutations in RB and p53 genes are significant carcinogenic factors].
Wiman KG
Lakartidningen; 1992 Sep; 89(39):3169-74. PubMed ID: 1405928
[TBL] [Abstract][Full Text] [Related]
6. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours.
Donehower LA; Harvey M; Slagle BL; McArthur MJ; Montgomery CA; Butel JS; Bradley A
Nature; 1992 Mar; 356(6366):215-21. PubMed ID: 1552940
[TBL] [Abstract][Full Text] [Related]
7. Allelic phasing of a mouse chromosome 11 deficiency influences p53 tumorigenicity.
Biggs PJ; Vogel H; Sage M; Martin LA; Donehower LA; Bradley A
Oncogene; 2003 May; 22(21):3288-96. PubMed ID: 12761499
[TBL] [Abstract][Full Text] [Related]
8. Role of transgenic mice in identification and characterization of tumour suppressor genes.
Sharan SK; Bradley A
Cancer Surv; 1995; 25():143-59. PubMed ID: 8718516
[TBL] [Abstract][Full Text] [Related]
9. Cell lineage-specific effects associated with multiple deficiencies of tumor susceptibility genes in Msh2(-/-)Rb(+/-) mice.
Nikitin AY; Liu CY; Flesken-Nikitin A; Chen CF; Chen PL; Lee WH
Cancer Res; 2002 Sep; 62(18):5134-8. PubMed ID: 12234974
[TBL] [Abstract][Full Text] [Related]
10. Effects of heterozygosity for the Rb-1t19neo allele in the mouse.
Harrison DJ; Hooper ML; Armstrong JF; Clarke AR
Oncogene; 1995 Apr; 10(8):1615-20. PubMed ID: 7731716
[TBL] [Abstract][Full Text] [Related]
11. Inactivation of p53 enhances sensitivity to multiple chemotherapeutic agents.
Hawkins DS; Demers GW; Galloway DA
Cancer Res; 1996 Feb; 56(4):892-8. PubMed ID: 8631030
[TBL] [Abstract][Full Text] [Related]
12. Tumor suppressor activity of RB and p53 genes in human breast carcinoma cells.
Wang NP; To H; Lee WH; Lee EY
Oncogene; 1993 Feb; 8(2):279-88. PubMed ID: 8426737
[TBL] [Abstract][Full Text] [Related]
13. A mutant p53 transgene accelerates tumour development in heterozygous but not nullizygous p53-deficient mice.
Harvey M; Vogel H; Morris D; Bradley A; Bernstein A; Donehower LA
Nat Genet; 1995 Mar; 9(3):305-11. PubMed ID: 7773294
[TBL] [Abstract][Full Text] [Related]
14. Nf1;Trp53 mutant mice develop glioblastoma with evidence of strain-specific effects.
Reilly KM; Loisel DA; Bronson RT; McLaughlin ME; Jacks T
Nat Genet; 2000 Sep; 26(1):109-13. PubMed ID: 10973261
[TBL] [Abstract][Full Text] [Related]
15. Emergent issues in the genetics of intestinal neoplasia.
Dove WF; Gould KA; Luongo C; Moser AR; Shoemaker AR
Cancer Surv; 1995; 25():335-55. PubMed ID: 8718526
[TBL] [Abstract][Full Text] [Related]
16. Developmental defects and tumor predisposition in Rb mutant mice.
Vooijs M; Berns A
Oncogene; 1999 Sep; 18(38):5293-303. PubMed ID: 10498881
[TBL] [Abstract][Full Text] [Related]
17. Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis.
Lee EY; Chang CY; Hu N; Wang YC; Lai CC; Herrup K; Lee WH; Bradley A
Nature; 1992 Sep; 359(6393):288-94. PubMed ID: 1406932
[TBL] [Abstract][Full Text] [Related]
18. Gain of function mutations in p53.
Dittmer D; Pati S; Zambetti G; Chu S; Teresky AK; Moore M; Finlay C; Levine AJ
Nat Genet; 1993 May; 4(1):42-6. PubMed ID: 8099841
[TBL] [Abstract][Full Text] [Related]
19. Altered messenger RNA and unique mutational profiles of p53 and Rb in human esophageal carcinomas.
Huang Y; Meltzer SJ; Yin J; Tong Y; Chang EH; Srivastava S; McDaniel T; Boynton RF; Zou ZQ
Cancer Res; 1993 Apr; 53(8):1889-94. PubMed ID: 8467510
[TBL] [Abstract][Full Text] [Related]
20. Spontaneous and irradiation-induced tumor susceptibility in BRCA2 germline mutant mice and cooperative effects with a p53 germline mutation.
McAllister KA; Houle CD; Malphurs J; Ward T; Collins NK; Gersch W; Wharey L; Seely JC; Betz L; Bennett LM; Wiseman RW; Davis BJ
Toxicol Pathol; 2006; 34(2):187-98. PubMed ID: 16546942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
